Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109941794 | 10994179 | 4 | F | 2006 | 20160719 | 20150407 | 20160930 | PER | US-ASTRAZENECA-2007BM08696 | ASTRAZENECA | 66.00 | YR | F | Y | 63.50000 | KG | 20160930 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109941794 | 10994179 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 109941794 | 10994179 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A262404 | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 109941794 | 10994179 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A386328 | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 109941794 | 10994179 | 4 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | AAA1473 | 0 | 2 | MG | /wk | |||||||
| 109941794 | 10994179 | 5 | C | ASA | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 109941794 | 10994179 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 2000 | MG | QD | ||||||||
| 109941794 | 10994179 | 7 | C | GLYNASE | GLYBURIDE | 1 | Oral | 0 | 6 | MG | BID | ||||||||
| 109941794 | 10994179 | 8 | C | DRUG USED IN DIABETES | UNSPECIFIED INGREDIENT | 1 | Oral | 0 | 2000 | MG | QD | ||||||||
| 109941794 | 10994179 | 9 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 0 | 22 | IU | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109941794 | 10994179 | 1 | Insulin-requiring type 2 diabetes mellitus |
| 109941794 | 10994179 | 2 | Insulin-requiring type 2 diabetes mellitus |
| 109941794 | 10994179 | 3 | Insulin-requiring type 2 diabetes mellitus |
| 109941794 | 10994179 | 4 | Type 2 diabetes mellitus |
| 109941794 | 10994179 | 7 | Insulin-requiring type 2 diabetes mellitus |
| 109941794 | 10994179 | 8 | Insulin-requiring type 2 diabetes mellitus |
| 109941794 | 10994179 | 9 | Insulin-requiring type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109941794 | 10994179 | Injection site bruising | |
| 109941794 | 10994179 | Injection site erythema | |
| 109941794 | 10994179 | Injection site haemorrhage | |
| 109941794 | 10994179 | Injection site mass | |
| 109941794 | 10994179 | Muscle spasms | |
| 109941794 | 10994179 | Product quality issue | |
| 109941794 | 10994179 | Varicose vein | |
| 109941794 | 10994179 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109941794 | 10994179 | 1 | 200604 | 200605 | 0 | |
| 109941794 | 10994179 | 2 | 200605 | 0 | ||
| 109941794 | 10994179 | 4 | 20130318 | 0 | ||
| 109941794 | 10994179 | 9 | 200805 | 0 |